(EMAILWIRE.COM, November 18, 2020 ) The active implantable medical devices market is expected to witness significant growth in the coming years. The growing aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries are some of the factors driving the growth of this market.

According MarketsandMarkets Research - The Active Implantable Medical Devices Market is estimated to grow at a CAGR of 7.8%, to reach USD 26.75 Billion.

The Key Factors Who will Drives the Market Growth?

- Increasing Burden of Cardiovascular Diseases
- Rising Prevalence of Neurological Disorders
- Investments and Funds to Develop Technologically Advanced Products
- Expanded Applications of Neurostimulators
- Favorable Reimbursement Scenario for Ent Procedures in Developed Countries

Active Implantable Medical Devices Market Opportunities:

- Emerging Markets Offer Significant Growth Opportunities
- Development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102063992

Market Segmentation in Depth:

Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices.

the implantable cardioverter defibrillators segment accounted for the largest share of the global active implantable medical devices market. However, the implantable hearing devices segment is expected to witness the highest growth in the next five years. The growth of the implantable hearing devices is mainly attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102063992

North America is the largest regional segment for the active implantable medical devices market. The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.

Medtronic plc (Ireland), Abbott Laboratories (U.S.), and Boston Scientific Corporation (U.S.) held the major share of the implantable cardiovascular and neurostimulators devices market. Whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), and William Demant Holding A/S (Denmark) held the major share of the implantable hearing devices market.